Ocuphire Pharma Inc. buy krebskrebs
Start price
07.02.22
/
50%
€2.58
Target price
07.02.23
€3.20
Performance (%)
26.55%
End price
08.02.23
€3.27
Summary
This prediction ended on 08.02.23 with a price of €3.27. The BUY prediction by krebskrebs finished with a performance of 26.55%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Ocuphire Pharma Inc. | -6.730% | -6.730% | -65.801% |
iShares Core DAX® | 1.851% | 5.158% | 17.711% |
iShares Nasdaq 100 | 1.573% | 2.589% | 39.053% |
iShares Nikkei 225® | -0.412% | -2.857% | 13.501% |
iShares S&P 500 | 1.128% | 2.485% | 29.871% |
Comments by krebskrebs for this prediction
In the thread Ocuphire Pharma Inc. diskutieren
Buy mit Kursziel 3,2
In the thread Trading Ocuphire Pharma Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten
Stopped prediction by krebskrebs for Ocuphire Pharma Inc.
Ocuphire Pharma Inc.
Start price
Target price
Perf. (%)
€7.00
05.10.20
05.10.20
€10.32
04.11.21
04.11.21
-46.29%
05.11.21
05.11.21